Environmental Rheumatology
Environmental triggers for idiopathic inflammatory myopathies: unravelling the known and unknown
C. Cardelli1, F. Trentin2, F. Fattorini3, M. Diomedi4, E. Laurino5, S. Barsotti6, M. Mosca7, L. Carli8
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa; and Department of Medical Biotechnologies, University of Siena, Italy.
- Rheumatology Unit, Azienda Sanitaria Friuli-Occidentale, Pordenone, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Rheumatology Outpatient Clinic and Internal Medicine, Hospital of Livorno, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy. 81clinda@gmail.com
CER17788
2025 Vol.43, N°2
PI 0186, PF 0192
Environmental Rheumatology
Free to view
(click on article PDF icon to read the article)
PMID: 39907588 [PubMed]
Received: 20/04/2024
Accepted : 18/11/2024
In Press: 05/02/2025
Published: 26/02/2025
Abstract
Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of rare connective tissues diseases that usually share the common feature of immune-mediated muscle or lung injury. Whereas their pathogenesis is widely recognised as multifactorial, the specific triggers initiating their onset remain largely elusive. Factors such as infections, inhalants, or geoclimatic variables are implicated, yet due to the limitations inherent in studies involving small and non-homogeneous cohorts, findings often appear fragmented and inconclusive. This review endeavours to present the most updated evidence regarding the influence of environmental factors in determining the onset of IIM, with the aim of offering insight to optimise the routinary management of affected patients.